PMID- 38316548 OWN - NLM STAT- MEDLINE DCOM- 20240403 LR - 20240409 IS - 1365-2567 (Electronic) IS - 0019-2805 (Linking) VI - 172 IP - 1 DP - 2024 May TI - Chromatin-binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation. PG - 109-126 LID - 10.1111/imm.13758 [doi] AB - Dendritic cells (DCs) are the most significant antigen presenting cells of the immune system, critical for the activation of naive T cells. The pathways controlling DC development, maturation, and effector function therefore require precise regulation to allow for an effective induction of adaptive immune response. MYSM1 is a chromatin binding deubiquitinase (DUB) and an activator of gene expression via its catalytic activity for monoubiquitinated histone H2A (H2A-K119ub), which is a highly abundant repressive epigenetic mark. MYSM1 is an important regulator of haematopoiesis in mouse and human, and a systemic constitutive loss of Mysm1 in mice results in a depletion of many haematopoietic progenitors, including DC precursors, with the downstream loss of most DC lineage cells. However, the roles of MYSM1 at the later checkpoints in DC development, maturation, activation, and effector function at present remain unknown. In the current work, using a range of novel mouse models (Mysm1(fl)Cre(ERT2), Mysm1(fl)CD11c-cre, Mysm1(DN)), we further the understanding of MYSM1 functions in the DC lineage: assessing the requirement for MYSM1 in DC development independently of other complex developmental phenotypes, exploring its role at the later checkpoints in DC maintenance and activation in response to microbial stimulation, and testing the requirement for the DUB catalytic activity of MYSM1 in these processes. Surprisingly, we demonstrate that MYSM1 expression and catalytic activity in DCs are dispensable for the maintenance of DC numbers in vivo or for DC activation in response to microbial stimulation. In contrast, MYSM1 acts via its DUB catalytic activity specifically in haematopoietic progenitors to allow normal DC lineage development, and its loss results not only in a severe DC depletion but also in the production of functionally altered DCs, with a dysregulation of many housekeeping transcriptional programs and significantly altered responses to microbial stimulation. CI - (c) 2024 The Authors. Immunology published by John Wiley & Sons Ltd. FAU - Mousa, Marwah AU - Mousa M AD - Department of Physiology, McGill University, Montreal, Quebec, Canada. AD - McGill University Research Centre on Complex Traits, McGill University, Montreal, Quebec, Canada. FAU - Liang, Yue AU - Liang Y AD - Department of Physiology, McGill University, Montreal, Quebec, Canada. AD - McGill University Research Centre on Complex Traits, McGill University, Montreal, Quebec, Canada. FAU - Tung, Lin Tze AU - Tung LT AD - Department of Physiology, McGill University, Montreal, Quebec, Canada. AD - McGill University Research Centre on Complex Traits, McGill University, Montreal, Quebec, Canada. FAU - Wang, HanChen AU - Wang H AD - Department of Physiology, McGill University, Montreal, Quebec, Canada. AD - McGill University Research Centre on Complex Traits, McGill University, Montreal, Quebec, Canada. FAU - Krawczyk, Connie AU - Krawczyk C AUID- ORCID: 0000-0002-2468-5986 AD - Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, Michigan, United States. FAU - Langlais, David AU - Langlais D AD - McGill University Research Centre on Complex Traits, McGill University, Montreal, Quebec, Canada. AD - Department of Human Genetics, McGill University Genome Centre, McGill University, Montreal, Quebec, Canada. AD - Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada. FAU - Nijnik, Anastasia AU - Nijnik A AUID- ORCID: 0000-0001-6048-4631 AD - Department of Physiology, McGill University, Montreal, Quebec, Canada. AD - McGill University Research Centre on Complex Traits, McGill University, Montreal, Quebec, Canada. LA - eng GR - CAPMC/CIHR/Canada GR - CAPMC/CIHR/Canada PT - Journal Article DEP - 20240205 PL - England TA - Immunology JT - Immunology JID - 0374672 RN - 0 (Chromatin) RN - EC 3.4.- (Endopeptidases) RN - 0 (Histones) RN - 0 (MYSM1 protein, human) RN - 0 (Trans-Activators) RN - EC 3.4.19.12 (Ubiquitin-Specific Proteases) RN - EC 3.4.19.12 (MYSM1 protein, mouse) SB - IM MH - Animals MH - Humans MH - Mice MH - Cell Differentiation MH - Chromatin/genetics MH - Dendritic Cells/metabolism MH - Endopeptidases/genetics/metabolism MH - Histones/metabolism MH - Mice, Knockout MH - *Trans-Activators/genetics/metabolism MH - *Ubiquitin-Specific Proteases/genetics/metabolism OTO - NOTNLM OT - cell differentiation OT - dendritic cells OT - flow cytometry OT - gene regulation OT - transgenic/knockout mice EDAT- 2024/02/06 00:42 MHDA- 2024/04/03 06:45 CRDT- 2024/02/05 21:37 PHST- 2023/07/23 00:00 [received] PHST- 2024/01/08 00:00 [accepted] PHST- 2024/04/03 06:45 [medline] PHST- 2024/02/06 00:42 [pubmed] PHST- 2024/02/05 21:37 [entrez] AID - 10.1111/imm.13758 [doi] PST - ppublish SO - Immunology. 2024 May;172(1):109-126. doi: 10.1111/imm.13758. Epub 2024 Feb 5.